Finally, other proteins identified in our 4 × 4 proteomic comparison of PDAC vs HC organoid EVs with more variability in the larger PDAC panel (PTPRJ, MUC16, TAOK1) are also reported markers of tumor-development in several cancer models77–79. This evidence concerns the gene MUC16 and neoplasm.